• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION SYNERGY; BIODEGRADABLE POLYMER DRUG ELUTING CORONARY STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION SYNERGY; BIODEGRADABLE POLYMER DRUG ELUTING CORONARY STENT SYSTEM Back to Search Results
Model Number 10602
Medical Device Problem Code Break (1069)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 02/22/2021
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that shaft break occurred.The target lesion was located in the moderately tortuous and calcified left anterior descending artery.A 3.50 x 16 mm synergy xd drug eluting stent was advanced for treatment of coronary blockage.However, during the attempt to cross the tight lesion, the shaft of the device fractured.The device fragments were completely retrieved from the guide and the procedure was completed successfully.No patient complications were reported.
 
Additional Manufacturer Narrative
B5.Describe event or problem- corrected.Device evaluated by mfr: the synergy ii us mr 3.50 x 16mm stent delivery system was returned for analysis.Examination of the crimped stent via scope found no issues with the stent.There were no signs of damage, stretching or lifting of the stent struts.The stent showed no signs of movement and was set between the proximal and distal marker bands.The crimped stent outer diameter was measured and the result is within maximum crimped stent profile measurement.The balloon cones were reviewed, and no issues were noted.The balloon wings were tightly wrapped and evenly folded and were not subjected to positive pressure.A visual examination of the bumper tip showed no signs of damage.A visual and tactile examination of the hypotube found multiple kinks and a break 38.5 cm distal to the distal end of the strain relief.A visual examination of the outer and inner lumen and mid-shaft section found no issues along the shaft polymer extrusion.No other issues were identified during the product analysis.
 
Event or Problem Description
It was reported that shaft break occurred.The target lesion was located in the moderately tortuous and calcified left anterior descending artery.A 3.50 x 16 mm synergy xd drug eluting stent was advanced for treatment of coronary blockage.However, during the attempt to cross the tight lesion, the shaft of the device fractured.The device fragments were completely retrieved from the guide and the procedure was completed successfully.No patient complications were reported.It was further reported that the device was synergy ii and not synergy xd as previously reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNERGY
Common Device Name
BIODEGRADABLE POLYMER DRUG ELUTING CORONARY STENT SYSTEM
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
MDR Report Key11485671
Report Number2134265-2021-02708
Device Sequence Number16997397
Product Code NIQ
UDI-Device Identifier08714729840121
UDI-Public08714729840121
Combination Product (Y/N)Y
Initial Reporter StateTN
Initial Reporter CountryUS
PMA/510(K) Number
P150003
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 04/13/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date12/08/2022
Device Model Number10602
Device Catalogue Number10602
Device Lot Number0026548912
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/11/2021
Initial Date Received by Manufacturer 02/24/2021
Supplement Date Received by Manufacturer03/25/2021
Initial Report FDA Received Date03/15/2021
Supplement Report FDA Received Date04/13/2021
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
-
-